Skip to content

Sport as Therapy: a 6-months Lifestyle-Intervention for Patients With Coronary Artery Disease and/or Diabetes

A 6-months Lifestyle Intervention With Interval and Resistance Exercise in Patients With Coronary Artery Disease and Diabetes Mellitus in a Community Based Setting

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03208751
Enrollment
500
Registered
2017-07-06
Start date
2011-04-01
Completion date
2020-01-01
Last updated
2019-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Diabetes Mellitus, Type 2, Exercise Training

Brief summary

Regular exercise training has shown to improve exercise capacity in patients with cardiovascular disease. The feasibility and transferability of exercise training in a community based cardiovascular rehabilitation setting is currently less well investigated. The objective of this study is to translate regular exercise training into a community based setting. A 6 months training intervention program with lifestyle counseling is performed, with both supervised training in rehabilitation centres as well as home based training. The aim of the project is to implement this program for a wider patient population and to improve exercise capacity, diastolic function as well as cardiometabolic parameters.

Detailed description

From 2011, patients insured at Techniker health insurance company with diagnosed coronary heart disease, heart failure and/or diabetes mellitus are being included in a 6-months training program. Training is performed 3 times weekly for 6 weeks, then twice weekly for another 6 weeks, while patients are asked to do home based training. The last phase of 12 weeks, supervised training is only once/week. Patients are asked to perform exercise training 3-5 times weekly. At the beginning as well as after 3 and 6 months, patients present for medical check-up with cardiorespiratory exercise testing from which training instructions are drawn. Training-intensity begins with moderate continuous training and switches to higher intensity interval training after 6 weeks. Resistance training starts after 6 weeks and is performed within the supervised training. All patients were offered an individual nutritional counseling.

Interventions

BEHAVIORALExercise training

Exercise intervention was divided into 3 phases: Phase 1: 6 weeks of moderate continuous training (MCT) 20 to 40 minutes at intensity of 60% of VO2peak, 3 times/week Phase 2: 6 weeks of moderate intensity interval training (MIIT) 30-40 min, intensity 60 to 80% of VO2peak, twice weekly plus at least once weekly MCT home based training Phase 3 (after performing new exercise testing to adapt training intensities): 12 weeks of MIIT 40 min once/week, intensity 60-80/85% of VO2peak, plus at least twice weekly home based MCT. From phase 2, supervised sessions included resistance training of at least 3 muscle groups, 3x15 repetitions at moderate intensity (Borg 12-14). Nutritional counseling is offered up to 4 times in 6 months on an individual basis.

Sponsors

Technical University of Munich
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

A single-arm intervention with exercise training as secondary prevention strategy

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Coronary artery disease and/or diabetes mellitus * Heart failure

Exclusion criteria

* all conditions which are not compatible with exercise training: * severe orthopedic disorders * severe psychiatric disease * severe valve insufficiency * presence of myocardial ischemia (decision made by cardiologist)

Design outcomes

Primary

MeasureTime frameDescription
Change in VO2peak in ml/kg/min6 monthsExercise capacity measured by cardiorespiratory exercise testing from start to the end of 6 months training intervention

Secondary

MeasureTime frameDescription
Change in hsCRP6 monthshigh sensitivity C-reactive protein, as an inflammation marker and risk marker for further CAD events
Change in E/e'6 monthsE/e' is an echocardiographic marker for diastolic function, an E/e' \< 8 is considered as normal
Change in quality of life measured by SF-366 monthsThe short form (SF-36) is a validated questionnaire for quality of life, the physical and psychical sum scale are measured
Change in insulin IU6 monthsInsulin dosage is measured in IE (international units)
Change in HDL- and LDL- cholesterol as well as triglycerides6 monthsall measured in mg/dl
Change in HbA1c for patients with diabetes6 monthsGlycated hemoglobin \>5,7 corresponds to glucose intolerance, \> 6,5 is diagnosed diabetes mellitus
Change in Watts at anaerobic threshold VAT6 monthsVAT= ventilatory anaerobic threshold, measured by cardiopulmonary exercise testing
Change in Watts at anaerobic threshold RCP6 monthsRCP= respiratory compensation point, measured by cardiopulmonary exercise testing
Change in max. Watts6 monthsOn bicycle ergometry, Watts are measured
Change in max. Watts/kg bodyweight6 monthsmax. Watts indexed b body weight
Change in Adiponectin6 monthsAdiponectin is an adipokine which is released by fat tissue

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026